Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: A longitudinal data analysis

Identifieur interne : 002C86 ( Main/Exploration ); précédent : 002C85; suivant : 002C87

Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: A longitudinal data analysis

Auteurs : Michelle Petri [États-Unis] ; Christiana Lakatta [États-Unis] ; Laurence Magder [États-Unis] ; Daniel Goldman [États-Unis]

Source :

RBID : ISTEX:4BA1895A5613AD02AF90EDD1D778550FC0629080

English descriptors

Abstract

Abstract: purpose: To determine the effect of prednisone dose and hydroxychloroquine dose on the coronary artery disease risk factors serum cholesterol level, mean arterial blood pressure, and weight in patients with systemic lupus erythematosus.patients and methods: A longitudinal cohort study of 264 patients with systemic lupus erythematosus was conducted. For all patients in the cohort, serum cholesterol, mean arterial pressure, weight, prednisone dose, hydroxychloroquine dose, and other potential confounding variables were recorded at each visit. Regression analysis appropriate for longitudinal data was used to assess the effect of prednisone on serum cholesterol and mean arterial pressure. To assess the effect of prednisone on weight, patients' weights were compared 90 days before and after a 10-mg or 20-mg increase in prednisone.results: A total of 3,027 patient visits were analyzed. In the regression model for serum cholesterol, a change in prednisone dose of 10 mg was associated with a change in cholesterol of 7.5 ± 1.46 (SE) mg% after adjustment for the other significant variables in the model, including sex, race, hydroxychloroquine dose, and proteinuria. In the regression model for hydroxychloroquine, the 200-mg and the 400-mg dose were both associated with lower serum cholesterol (8.9 ± 3.44 SE mg%). In the regression model for mean arterial blood pressure, a 10-mg change in prednisone dose led to a change in mean arterial blood pressure of 1.1 mm Hg after adjustment for age, weight, and antihypertensive drug use. A 10-mg increase in prednisone dose was associated with a mean weight change of 5.50 ± 1.23 (SE) lb.conclusions: Changes in prednisone dose led to definable changes in risk factors for coronary artery disease, even after adjustment for other variables known to affect these risk factors. According to longitudinal regression analysis, hydroxychloroquine therapy was associated with lower serum cholesterol.

Url:
DOI: 10.1016/0002-9343(94)90151-1


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: A longitudinal data analysis</title>
<author>
<name sortKey="Petri, Michelle" sort="Petri, Michelle" uniqKey="Petri M" first="Michelle" last="Petri">Michelle Petri</name>
</author>
<author>
<name sortKey="Lakatta, Christiana" sort="Lakatta, Christiana" uniqKey="Lakatta C" first="Christiana" last="Lakatta">Christiana Lakatta</name>
</author>
<author>
<name sortKey="Magder, Laurence" sort="Magder, Laurence" uniqKey="Magder L" first="Laurence" last="Magder">Laurence Magder</name>
</author>
<author>
<name sortKey="Goldman, Daniel" sort="Goldman, Daniel" uniqKey="Goldman D" first="Daniel" last="Goldman">Daniel Goldman</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:4BA1895A5613AD02AF90EDD1D778550FC0629080</idno>
<date when="1994" year="1994">1994</date>
<idno type="doi">10.1016/0002-9343(94)90151-1</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-KL16S38Q-F/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000077</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000077</idno>
<idno type="wicri:Area/Istex/Curation">000077</idno>
<idno type="wicri:Area/Istex/Checkpoint">001A71</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001A71</idno>
<idno type="wicri:doubleKey">0002-9343:1994:Petri M:effect:of:prednisone</idno>
<idno type="wicri:Area/Main/Merge">002D46</idno>
<idno type="wicri:Area/Main/Curation">002C86</idno>
<idno type="wicri:Area/Main/Exploration">002C86</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: A longitudinal data analysis</title>
<author>
<name sortKey="Petri, Michelle" sort="Petri, Michelle" uniqKey="Petri M" first="Michelle" last="Petri">Michelle Petri</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Molecular and Clinical Rheumatology, Department of Medicine, Johns Hopkins University Medical Institutions and School of Hygiene and Public Health, Baltimore, Maryland</wicri:regionArea>
<placeName>
<region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lakatta, Christiana" sort="Lakatta, Christiana" uniqKey="Lakatta C" first="Christiana" last="Lakatta">Christiana Lakatta</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Molecular and Clinical Rheumatology, Department of Medicine, Johns Hopkins University Medical Institutions and School of Hygiene and Public Health, Baltimore, Maryland</wicri:regionArea>
<placeName>
<region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Magder, Laurence" sort="Magder, Laurence" uniqKey="Magder L" first="Laurence" last="Magder">Laurence Magder</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Biostatistics, Johns Hopkins University Medical Institutions and School of Hygiene and Public Health, Baltimore, Maryland</wicri:regionArea>
<placeName>
<region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Goldman, Daniel" sort="Goldman, Daniel" uniqKey="Goldman D" first="Daniel" last="Goldman">Daniel Goldman</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Molecular and Clinical Rheumatology, Department of Medicine, Johns Hopkins University Medical Institutions and School of Hygiene and Public Health, Baltimore, Maryland</wicri:regionArea>
<placeName>
<region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">The American Journal of Medicine</title>
<title level="j" type="abbrev">AJM</title>
<idno type="ISSN">0002-9343</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1994">1994</date>
<biblScope unit="volume">96</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="254">254</biblScope>
<biblScope unit="page" to="259">259</biblScope>
</imprint>
<idno type="ISSN">0002-9343</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0002-9343</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>American journal</term>
<term>Antihypertensive</term>
<term>Antihypertensive drug</term>
<term>Arch intern</term>
<term>Arterial blood pressure</term>
<term>Arterial pressure</term>
<term>Artery disease</term>
<term>Artery disease risk factors</term>
<term>Biol chem</term>
<term>Black race</term>
<term>Clinical rheumatology</term>
<term>Cohort</term>
<term>Cohort visit database</term>
<term>Coronary artery disease</term>
<term>Coronary artery disease risk factors</term>
<term>Coronary heart disease</term>
<term>Corticosteroid therapy</term>
<term>Cumulative history database</term>
<term>Database</term>
<term>Erythematosus</term>
<term>Factor modelled</term>
<term>Female gender</term>
<term>Hopkins lupus cohort</term>
<term>Human fibroblasts</term>
<term>Hydroxychloroquine</term>
<term>Hydroxychloroquine dose</term>
<term>Hypertension</term>
<term>Increase weight</term>
<term>Johns hopkins hospital</term>
<term>Johns hopkins university school</term>
<term>Lipid research clinics</term>
<term>Longitudinal</term>
<term>Longitudinal data</term>
<term>Longitudinal data analysis</term>
<term>Lower serum cholesterol level</term>
<term>Lupus</term>
<term>Major cause</term>
<term>Medicine volume</term>
<term>Other factors</term>
<term>Other variables</term>
<term>Petri</term>
<term>Prednisone</term>
<term>Prednisone dosage</term>
<term>Prednisone dose</term>
<term>Premature atherosclerosis</term>
<term>Primary prevention trial results</term>
<term>Proteolytic degradation</term>
<term>Public health</term>
<term>Regression analysis</term>
<term>Regression model</term>
<term>Regression models</term>
<term>Rheumatic disease</term>
<term>Risk factors</term>
<term>Serum cholesterol</term>
<term>Serum cholesterol level</term>
<term>Serum cholesterol levels</term>
<term>Serum creatinine level</term>
<term>Significant predictors</term>
<term>Smoking status</term>
<term>Systemic</term>
<term>Systemic lupus erythematosus</term>
<term>Systemic lupus patients</term>
<term>Typical risk factors</term>
<term>Univariate analysis</term>
<term>Urine</term>
<term>Urine protein</term>
<term>Urine protein level</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: purpose: To determine the effect of prednisone dose and hydroxychloroquine dose on the coronary artery disease risk factors serum cholesterol level, mean arterial blood pressure, and weight in patients with systemic lupus erythematosus.patients and methods: A longitudinal cohort study of 264 patients with systemic lupus erythematosus was conducted. For all patients in the cohort, serum cholesterol, mean arterial pressure, weight, prednisone dose, hydroxychloroquine dose, and other potential confounding variables were recorded at each visit. Regression analysis appropriate for longitudinal data was used to assess the effect of prednisone on serum cholesterol and mean arterial pressure. To assess the effect of prednisone on weight, patients' weights were compared 90 days before and after a 10-mg or 20-mg increase in prednisone.results: A total of 3,027 patient visits were analyzed. In the regression model for serum cholesterol, a change in prednisone dose of 10 mg was associated with a change in cholesterol of 7.5 ± 1.46 (SE) mg% after adjustment for the other significant variables in the model, including sex, race, hydroxychloroquine dose, and proteinuria. In the regression model for hydroxychloroquine, the 200-mg and the 400-mg dose were both associated with lower serum cholesterol (8.9 ± 3.44 SE mg%). In the regression model for mean arterial blood pressure, a 10-mg change in prednisone dose led to a change in mean arterial blood pressure of 1.1 mm Hg after adjustment for age, weight, and antihypertensive drug use. A 10-mg increase in prednisone dose was associated with a mean weight change of 5.50 ± 1.23 (SE) lb.conclusions: Changes in prednisone dose led to definable changes in risk factors for coronary artery disease, even after adjustment for other variables known to affect these risk factors. According to longitudinal regression analysis, hydroxychloroquine therapy was associated with lower serum cholesterol.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Maryland</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Maryland">
<name sortKey="Petri, Michelle" sort="Petri, Michelle" uniqKey="Petri M" first="Michelle" last="Petri">Michelle Petri</name>
</region>
<name sortKey="Goldman, Daniel" sort="Goldman, Daniel" uniqKey="Goldman D" first="Daniel" last="Goldman">Daniel Goldman</name>
<name sortKey="Lakatta, Christiana" sort="Lakatta, Christiana" uniqKey="Lakatta C" first="Christiana" last="Lakatta">Christiana Lakatta</name>
<name sortKey="Magder, Laurence" sort="Magder, Laurence" uniqKey="Magder L" first="Laurence" last="Magder">Laurence Magder</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002C86 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002C86 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:4BA1895A5613AD02AF90EDD1D778550FC0629080
   |texte=   Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: A longitudinal data analysis
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021